To further explore the impact of m6A genes on pancreatic cancer prognosis, we conducted transcriptomic analyses and identified METTL3 and METTL16 as the key m6A ‘writer’ genes associated with better patient outcomes. This evidence concerns the gene METTL16 and pancreatic neoplasm.